SIX •
Healthcare •
Biotechnology •
Quote as of 07/29/2026 14:31
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeSIX
Market Capitalization2,801.58 mln
Earnings Date07/24/2026
EPS
24.57
Exceptional
P / E
2.12
Deeply undervalued
Piotroski F-Score
5
/ 9
Neutral
Relative Strength
92
/ 100
Top performer
Debt / Equity
0.00
Debt-free
ROE
34.66
Very strong
Business Description
Founded in Switzerland in 1993, BB Biotech AG is an investment fund run by Bellevue Asset Management AG. The fund buys shares in publicly traded companies around the world that develop medicines and diagnostic tools using biotechnology. Investment decisions are guided by in-depth research into each company's underlying business fundamentals.
